Matar, P. (2022). Biosimilarity is not a transitive property: Implication for interchangeability, naming and pharmacovigilance. Web
Citación estilo ChicagoMatar, Pablo. Biosimilarity Is Not a Transitive Property: Implication for Interchangeability, Naming and Pharmacovigilance. 2022.
Cita MLAMatar, Pablo. Biosimilarity Is Not a Transitive Property: Implication for Interchangeability, Naming and Pharmacovigilance. 2022.
Precaución: Estas citas no son 100% exactas.